Amlodipine accelerates bone healing in a stable closed femoral fracture model in mice
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Calcium channel blockers (CCBs), which are widely used in the treatment of hypertension, have been shown to influence bone metabolism. However, there is little information on whether CCBs also influence the process of fracture healing. Therefore, the effect of the CCB amlodipine on bone healing was studied in a stable closed fracture model in mice using intramedullary screw fixation. Bone healing was investigated by radiology, biomechanics, histomorphometry and Western blot analysis 2 and 5 weeks after fracture healing. Animals were treated daily (post operatively) per os using a gavage with amlodipine low dose (1 mg/ kg body weight, n = 20), amlodipine high dose (3 mg/kg body weight, n = 20) or vehicle (NaCl) (control, n = 20) serving as a negative control. At 2 and 5 weeks, histomorphometric analysis revealed a significantly larger amount of bone tissue within the callus of amlodipine low-dose- and high-dose-treated animals when compared to controls. This was associated with a smaller amount of cartilaginous and fibrous tissue, indicating an acceleration of fracture healing. Biomechanics showed a slightly, but not significantly, higher bending stiffness in amlodipine low-dose- and high-dose-treated animals. Western blot analysis revealed a significantly increased expression of bone morphogenetic protein (BMP)-2 and vascular endothelial growth factor (VEGF). Moreover, the analysis showed a 5-fold higher expression of osteoprotegerin (OPG) and a 10-fold elevated expression of the receptor activator of NF-κB ligand (RANKL), indicating an increased bone turnover. These findings demonstrated that amlodipine accelerated fracture healing by stimulating bone formation, callus remodelling and osteoclast activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In animal studies, amlodipine (114), cilostazol (115), L-arginin (116), sildenafil (117), and metformin (118) were shown to facilitate fracture healing.”
From Methods to accelerate fracture healing – a narrative review from a clinical perspective (2024) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · cited 1×
“On the other hand, OPG is a soluble decoy receptor for RANKL that interferes with RANKL-RANK binding, leading to an inhibition of osteoclastogenesis (Lacey et al., 1998; Simonet et al., 1997).”
BackgroundOsteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
OSTEOGENIC ACTIVITY OF THE FOURTEEN TYPES OF HUMAN BONE MORPHOGENETIC PROTEINS (BMPS)
CHENG, H., JIANG, W., PHILLIPS, F. M., HAYDON, R. C., PENG, Y., ZHOU, L., LUU, H. H., AN, N., BREYER, B., VANICHAKARN, P., et al. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200308000-00017 · Cited by 1,012
Osteoblast–osteoclast interactions
Chen, X., Wang, Z., Duan, N., Zhu, G., Schwarz, E. M., & Xie, C. (2018) · Connective Tissue Research · doi:10.1080/03008207.2017.1290085 · Cited by 873 · cited 1×
“Moreover, it is widely accepted that osteoblasts express RANKL and, thus, stimulate osteoclastogenesis themselves (Chen et al., 2018).”
BackgroundCarano, R. A. D., & Filvaroff, E. H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02866-6 · Cited by 746
Osteoclasts: What Do They Do and How Do They Do It?
Teitelbaum, S. L. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060834 · Cited by 730
Prevention of fracture healing in rats by an inhibitor of angiogenesis
Hausman, M. R., Schaffler, M. B., & Majeska, R. J. (2001) · Bone · doi:10.1016/s8756-3282(01)00608-1 · Cited by 384 · cited 1×
“The importance of a sufficient vascularisation is supported by experimental studies demonstrating that an inhibition of VEGF signalling leads to an impaired bone healing and non-union formation (Hausman et al., 2001).”
BackgroundSi, W., Kang, Q., Luu, H. H., Park, J. K., Luo, Q., Song, W.-X., Jiang, W., Luo, X., Li, X., Yin, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2955-2964.2006 · Cited by 272 · cited 1×
“CYR61 plays an important role in the process of bone healing by the stimulation of osteoblast differentiation and proliferation (Si et al., 2006).”
BackgroundGerstenfeld, L. C., Sacks, D. J., Pelis, M., Mason, Z. D., Graves, D. T., Barrero, M., Ominsky, M. S., Kostenuik, P. J., Morgan, E. F., & Einhorn, T. A. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081113 · Cited by 218 · cited 1×
“Cartilage resorption during fracture healing is associated with a peak in RANKL and OPG expression (Gerstenfeld et al., 2009).”
BackgroundApplication of Histomorphometric Methods to the Study of Bone Repair
Gerstenfeld, L. C., Wronski, T. J., Hollinger, J. O., & Einhorn, T. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050702 · Cited by 172 · cited 1×
“Structural indices were calculated using light microscopy with a 1.25× lens (Olympus BX60 Microscope; Zeiss Axio Cam and Axio Vision 3.1) according to the suggestion provided by Gerstenfeld et al. (2005) using the ImageJ Analysis System (NIH, Bethesda, MD, USA).”
MethodInfluentialBone grafting: Role of histocompatibility in transplantation
Goldberg, V. M., Powell, A., Shaffer, J. W., Zika, J., Bos, G. D., & Heiple, K. G. (1985) · Journal of Orthopaedic Research · doi:10.1002/jor.1100030401 · Cited by 159 · cited 1×
“Fracture healing was analysed according to the classification of Goldberg, with stage 0 indicating radiological nonunion, stage 1 indicating possible union and stage 2 indicating radiological union (Goldberg et al., 1985).”
MethodSchmidmaier, G., Wildemann, B., Cromme, F., Kandziora, F., Haas, N. P., & Raschke, M. (2002) · Bone · doi:10.1016/s8756-3282(02)00740-8 · Cited by 131 · cited 1×
“Loading was stopped individually in every case when the actual load-displacement curve deviated more than 1 % from linearity (Schoen et al., 2008).”
BackgroundEffect of cell‐based VEGF gene therapy on healing of a segmental bone defect
Li, R., Stewart, D. J., von Schroeder, H. P., Mackinnon, E. S., & Schemitsch, E. H. (2008) · Journal of Orthopaedic Research® · doi:10.1002/jor.20658 · Cited by 118 · cited 1×
“Moreover, treatment with VEGF significantly improves bone healing in animal models (Li et al., 2009).”
BackgroundCellular Actions and Pharmacology of the Calcium Channel Blocking Drugs
Katz, A. M., Hager, W. D., Messineo, F. C., & Pappano, A. J. (1984) · The American Journal of Medicine · doi:10.1016/s0002-9343(84)80078-9 · Cited by 90
Chondrocyte BMP2 signaling plays an essential role in bone fracture healing
Mi, M., Jin, H., Wang, B., Yukata, K., Sheu, T., Ke, Q. H., Tong, P., Im, H., Xiao, G., & Chen, D. (2012) · Gene · doi:10.1016/j.gene.2012.09.130 · Cited by 82 · cited 1×
“As a member of the transforming growth factor-β superfamily, BMP-2 induces bone formation in vivo by promoting differentiation of mesenchymal stem cells and osteoprogenitor cells into osteoblasts (Cheng et al., 2003; Mi et al., 2013).”
BackgroundDevelopment of a Stable Closed Femoral Fracture Model in Mice
Holstein, J. H., Matthys, R., Histing, T., Becker, S. C., Fiedler, M., Garcia, P., Meier, C., Pohlemann, T., & Menger, M. D. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.02.042 · Cited by 80 · cited 2×
“1d) and an intramedullary medical stainless-steel screw (18 mm length, 0.5 mm diameter) was implanted over the guidewire to stabilise the fracture (Holstein et al., 2009) (Fig.”
MethodInfluentialMelatonin Impairs Fracture Healing by Suppressing RANKL-Mediated Bone Remodeling
Histing, T., Anton, C., Scheuer, C., Garcia, P., Holstein, J. H., Klein, M., Matthys, R., Pohlemann, T., & Menger, M. D. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.08.036 · Cited by 70 · cited 1×
“Furthermore, inhibition of RANKL through treatment with melatonin and pantoprazole delays the process of bone remodelling and leads to an impaired fracture healing in mice (Histing et al., 2012a; 2012b).”
BackgroundSite Specific Effects of Zoledronic Acid during Tibial and Mandibular Fracture Repair
Yu, Y. Y., Lieu, S., Hu, D. P., Miclau, T., & Colnot, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031771 · Cited by 60 · cited 1×
“A possible explanation for these results contradicting the present study may be the fact that facial bones heal with more intramembranous ossification and less endochondral bone formation, whereas long tubular bones, such as the femur, heal mainly by endochondral ossification (Yu et al., 2012).”
ResultPantoprazole, a Proton Pump Inhibitor, Delays Fracture Healing in Mice
Histing, T., Stenger, D. P., Scheuer, C., Metzger, W., García, P., Holstein, J. H., Klein, M., Pohlemann, T., & Menger, M. D. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9601-x · Cited by 59
Sildenafil accelerates fracture healing in mice
Histing, T., Marciniak, K., Scheuer, C., Garcia, P., Holstein, J. H., Klein, M., Matthys, R., Pohlemann, T., & Menger, M. D. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21324 · Cited by 56 · cited 1×
“In line with this, selective inhibition of phosphodiesterase-3 (PDE-3) and PDE-5 accelerates fracture healing through a CYR61-associated pathway (Herath et al., 2015; Histing et al., 2011).”
BackgroundEffects of Various Antihypertensive Drugs on the Function of Osteoblast.
NISHIYA, Y., & SUGIMOTO, S. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.628 · Cited by 48
Bangalore, S. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3339 · Cited by 46
The immediate early gene product hCYR61 localizes to the secretory pathway in human osteoblasts
Lechner, A., Schütze, N., Siggelkow, H., Seufert, J., & Jakob, F. J. (2000) · Bone · doi:10.1016/s8756-3282(00)00294-5 · Cited by 45 · cited 1×
“The protein acts as an extracellular signalling molecule in human bone, regulated by 1α, 25-dihydroxyvitamin D3 (Lechner et al., 2000).”
BackgroundRitchie, C. K., Maercklein, P. B., & Fitzpatrick, L. A. (1994) · Endocrinology · doi:10.1210/endo.135.3.8070395 · Cited by 43 · cited 1×
“The authors assumed that the reduction in osteoclast function was caused by the binding of amlodipine to osteoclast calcium channels, resulting in an increased intracellular calcium concentration (Ritchie et al., 1994).”
BackgroundBeyond osteogenesis: an in vitro comparison of the potentials of six bone morphogenetic proteins
Rivera, J. C., Strohbach, C. A., Wenke, J. C., & Rathbone, C. R. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00125 · Cited by 42 · cited 2×
“Further analysis of the molecular pathways of BMP-2 revealed that it acts through various autocrine and paracrine mechanisms, such as the secretion of basic fibroblast growth factor (Rivera et al., 2013).”
BackgroundProtective effects of amlodipine and lacidipine on ovariectomy-induced bone loss in rats
Halıcı, Z., Börekçi, B., Özdemır, Y., Çadırcı, E., & Süleyman, H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.09.027 · Cited by 41 · cited 2×
“The dosages of 1 mg/kg and 3 mg/kg BW used in the present study corresponded to those used in previous experimental studies (Halici et al., 2008; Zivna et al., 2018).”
BackgroundMethodSchoen, M., Rotter, R., Schattner, S., Mittlmeier, T., Claes, L., Vollmar, B., & Gradl, G. (2008) · Journal of Orthopaedic Research · doi:10.1002/jor.20501 · Cited by 37 · cited 1×
“In fact, various clinical and experimental studies suggest that CCBs influence skeletal calcium metabolism due to the presence of L-type channels in osteoblastic cells (Shimizu et al., 2012).”
BackgroundBMP-2-coated mineral coated microparticles improve bone repair in atrophic non-unions
Orth, M., Kruse, N., Braun, B. J., Scheuer, C., Holstein, J. H., Khalil, A. S., Yu, X., Murphy, W. L., Pohlemann, T., Laschke, M. W., et al. (2017) · European Cells and Materials · doi:10.22203/ecm.v033a01 · Cited by 37 · cited 1×
“Several studies have demonstrated that the application of BMP2 also accelerates and improves bone healing in experimental murine animal models (Orth et al., 2017; Schmidmaier et al., 2002).”
BackgroundShimizu, H., Nakagami, H., Yasumasa, N., Osako, M. K., Kyutoku, M., Koriyama, H., Nakagami, F., Shimamura, M., Rakugi, H., & Morishita, R. (2011) · Hypertension Research · doi:10.1038/hr.2011.143 · Cited by 33 · cited 1×
“CYR61 plays an important role in the process of bone healing by the stimulation of osteoblast differentiation and proliferation (Si et al., 2006).”
BackgroundProtective effect of amlodipine against osteoporosis in stroke-prone spontaneously hypertensive rats
Ushijima, K., Liu, Y., Maekawa, T., Ishikawa, E., Motosugi, Y., Ando, H., Tsuruoka, S., & Fujimura, A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.039 · Cited by 32 · cited 2×
“Ushijima et al. (2010) postulated that amlodipine prevents a reduction in bone mineral density in stroke-prone spontaneously hypertensive rats through an inhibition of osteoclast activity.”
BackgroundResultMcBride, S. H., McKenzie, J. A., Bedrick, B. S., Kuhlmann, P., Pasteris, J. D., Rosen, V., & Silva, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096862 · Cited by 31 · cited 1×
“During bone formation, BMPs are secreted by osteoblasts within the extracellular matrix (McBride et al., 2014).”
BackgroundPark, H.-H., Han, M., Choi, H., Lee, Y. J., Kim, J. M., Cheong, J. H., Ryu, J. I., Lee, K., & Koh, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-52083-y · Cited by 31 · cited 1×
“Amlodipine exerts cyto-protective effects from oxidative stress (Choi et al., 2014; Park et al., 2019) and hypoxia-induced apoptosis (Nehra et al., 2014).”
BackgroundCellular actions and pharmacology of the calcium channel blocking drugs
Katz, A. M., Hager, W. D., Messineo, F. C., & Pappano, A. J. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90494-2 · Cited by 28 · cited 1×
“They act by blocking the voltagedependent calcium channels in arteriolar smooth muscle cells, thus reducing the peripheral vascular resistance and, as a consequence, blood pressure (Katz et al., 1984).”
BackgroundChoi, N.-Y., Choi, H., Park, H.-H., Lee, E.-H., Yu, H., Lee, K., Lee, Y. J., & Koh, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.016 · Cited by 22 · cited 2×
“Amlodipine exerts cyto-protective effects from oxidative stress (Choi et al., 2014; Park et al., 2019) and hypoxia-induced apoptosis (Nehra et al., 2014).”
BackgroundTeófilo, J. M., Brentegani, L. G., & Carvalho, T. L. L. (2001) · Archives of Oral Biology · doi:10.1016/s0003-9969(00)00132-1 · Cited by 22 · cited 4×
“During intramembranous healing of facial bones, however, amlodipine may have different and even adverse effects on regeneration as observed by Moraes et al. (2011) and Teófilo et al. (2001).”
BackgroundResultInfluentialMoraes, R. B., Côrrea, L., & Luz, J. G. D. C. (2010) · Oral and Maxillofacial Surgery · doi:10.1007/s10006-010-0237-6 · Cited by 21 · cited 4×
“During intramembranous healing of facial bones, however, amlodipine may have different and even adverse effects on regeneration as observed by Moraes et al. (2011) and Teófilo et al. (2001).”
BackgroundResultInfluentialStimulation of angiogenesis by cilostazol accelerates fracture healing in mice
Herath, S. C., Lion, T., Klein, M., Stenger, D., Scheuer, C., Holstein, J. H., Mörsdorf, P., Rollmann, M. F. R., Pohlemann, T., Menger, M. D., et al. (2015) · Journal of Orthopaedic Research® · doi:10.1002/jor.22967 · Cited by 20 · cited 1×
“In line with this, selective inhibition of phosphodiesterase-3 (PDE-3) and PDE-5 accelerates fracture healing through a CYR61-associated pathway (Herath et al., 2015; Histing et al., 2011).”
BackgroundRitchie, C. K. (1994) · Endocrinology · doi:10.1210/en.135.3.996 · Cited by 19
Protective Effect of Amlodipine on Rat Bone Tissue after Orchidectomy
Gradošová, I., Živná, H., Palička, V., Hubená, S., Švejkovská, K., & Živný, P. (2012) · Pharmacology · doi:10.1159/000335491 · Cited by 17 · cited 2×
“, 2001) and mitigates the negative effects of orchidectomy by enhancing bone mineral density in rats (Gradosova et al., 2012).”
BackgroundBlood pressure and α-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca
Civantos, B., & Aleixandre, A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.032 · Cited by 15
Cysteine-rich matricellular protein improves callus regenerate in a rabbit trauma model
Frey, S. P., Hoelscher‐Doht, S., Eden, L., Dannigkeit, S., Schütze, N., Meffert, R. H., & Jansen, H. (2012) · International Orthopaedics · doi:10.1007/s00264-012-1659-6 · Cited by 14 · cited 1×
“Frey et al. (2012) demonstrated in a rabbit trauma model that the local application of CYR61 improves callus regeneration, as indicated by an increased bone formation and torsional strength.”
BackgroundKarakuş, E., Halıcı, Z., Albayrak, A., Bayır, Y., Demirci, E., Aydın, A., Öztürk, B., Çadırcı, E., Ayan, A. K., Sahin, A., et al. (2015) · Inflammation · doi:10.1007/s10753-015-0254-6 · Cited by 14 · cited 3×
“Accordingly, the authors proposed that amlodipine may be used as a therapeutic agent for osteoporosis treatment in hypertensive patients (Karakus et al., 2016).”
BackgroundResultAntihypertensive Effects of Calcium Antagonists
Clément, D., Buyzere, M. L. D., & Duprez, D. A. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.7.16s · Cited by 11 · cited 1×
“Amlodipine, a dihydropyridine-type CCB of the third generation, was developed to improve the therapeutic efficiency of this class of drugs and, simultaneously, decreasing the frequency of adverse effects (Clement et al., 1994).”
BackgroundEffet d'un inhibiteur calcique, le v�rapamil, sur le d�veloppement des ossifications h�t�rotopiques
Duriez, J., Flautre, B., Blary, M. C., & Duriez, R. (1990) · International Orthopaedics · doi:10.1007/bf00182655 · Cited by 10 · cited 1×
“However, since CCBs interfere with the transportation of calcium through cell membranes, they may affect a range of metabolic processes, including bone metabolism (Duriez et al., 1990).”
BackgroundNehra, S., Bhardwaj, V., & Saraswat, D. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000130 · Cited by 9 · cited 2×
“, 2019) and hypoxia-induced apoptosis (Nehra et al., 2014).”
BackgroundEffects of Amlodipine on Bone Metabolism in Orchidectomised Spontaneously Hypertensive Rats
Živná, H., Gradošová, I., Živný, P., Čermáková, E., & Palička, V. (2018) · Pharmacology · doi:10.1159/000489666 · Cited by 4 · cited 1×
“The dosages of 1 mg/kg and 3 mg/kg BW used in the present study corresponded to those used in previous experimental studies (Halici et al., 2008; Zivna et al., 2018).”
MethodFeneck, R. O. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9781139062381.024 · Cited by 2
Research works printed but not linked: 1
- Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cifkova R, Dominiczak AF, Grassi G, Jordan J, Poulter NR, Rodgers A, Whelton PK (2018) Hypertension. Nat Rev Dis Primers 4: 18014. DOI: 10.1038/nrdp.2018. · doi:10.1038/nrdp.2018
Cited by
Advanced Progress of the Relationship Between Antihypertensive Drugs and Bone Metabolism
Zhang, R., Yin, H., Yang, M., Lei, X., Zhen, D., & Zhang, Z. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21648 · Cited by 43
Methods to accelerate fracture healing – a narrative review from a clinical perspective
Ganse, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1384783 · Cited by 33
Menger, M. M., Bauer, D., Bleimehl, M., Scheuer, C., Braun, B. J., Herath, S. C., Rollmann, M. F. R., Menger, M. D., Laschke, M. W., & Histing, T. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04441-8 · Cited by 12
“Successful bone regeneration requires osteoclastmediated cartilage and bone resorption within the callus tissue [50].”
BackgroundDevelopment of an ischemic fracture healing model in mice
Menger, M. M., Stutz, J., Ehnert, S., Nussler, A. K., Rollmann, M. F. R., Herath, S. C., Braun, B. J., Pohlemann, T., Menger, M. D., & Histing, T. (2022) · Acta Orthopaedica · doi:10.2340/17453674.2022.2529 · Cited by 11
“Of note, we observed a reliable femoral fracture consolidation at 5 weeks after surgery with the present model in previous studies (8,9).”
ResultMenger, M. M., Emmerich, M., Scheuer, C., Hans, S., Braun, B. J., Herath, S. C., Rollmann, M. F. R., Menger, M. D., Laschke, M. W., & Histing, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116291 · Cited by 7
Metadata
- Authors
- Department of Trauma and Reconstructive Surgery, E. K. U. T., Menger, M., Merscher, B., Scheuer, C., Braun, B., Herath, S., Rollmann, M., Stenger, D., Später, T., Pohlemann, T., Menger, M., & Histing, T.
- Affiliations
- Saarland University (DE)
- University of Tübingen (DE)
- Venue
- European Cells and Materials
- Publisher
- Forum Multimedia Publishing LLC
- Published
- 2021-05-24
- Volume
- 41
- Pages
- 592-602
- ISSN
- 1473-2262 (ISSN-L)
- OpenAlex
- W3164549844
- Cited by
- 16
- References
- 47
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 1
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- European Cells and Materials (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Servier
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- amlodipine, calcium channel blockers, fracture healing, femoral fracture, intramedullary screw fixation, BMP-2, vascular endothelial growth factor, osteoprotegerin, RANKL, bone turnover, osteoclast activity, bone formation
- MeSH terms
- Animals, Bone Screws, Calcium Channel Blockers, Bony Callus, Disease Models, Animal, Femoral Fractures, Femur, Osteoclasts, Osteogenesis, Bone Remodeling, Fracture Healing, Amlodipine, Vascular Endothelial Growth Factor A, Mice, RANK Ligand, Bone Morphogenetic Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.








